Analysts Set Teleflex Incorporated (NYSE:TFX) PT at $252.50

Shares of Teleflex Incorporated (NYSE:TFX) have been assigned a consensus rating of “Moderate Buy” from the seven ratings firms that are presently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $252.50.

Several analysts have recently commented on the stock. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Royal Bank of Canada decreased their price objective on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Truist Financial reduced their price objective on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. Finally, Mizuho reduced their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Simplify Asset Management Inc. purchased a new position in shares of Teleflex in the third quarter worth $4,800,000. JPMorgan Chase & Co. lifted its stake in shares of Teleflex by 14.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock worth $38,374,000 after purchasing an additional 19,466 shares during the period. Sumitomo Mitsui Trust Group Inc. lifted its position in Teleflex by 5.2% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company’s stock valued at $19,263,000 after purchasing an additional 5,322 shares in the last quarter. Lecap Asset Management Ltd. purchased a new stake in shares of Teleflex in the fourth quarter worth $729,000. Finally, LGT Capital Partners LTD. boosted its stake in Teleflex by 4.2% in the 3rd quarter. LGT Capital Partners LTD. now owns 231,685 shares of the medical technology company’s stock worth $57,300,000 after purchasing an additional 9,411 shares during the period. 95.62% of the stock is currently owned by institutional investors.

Teleflex Trading Down 0.1 %

NYSE TFX opened at $167.44 on Thursday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The business has a fifty day simple moving average of $178.15 and a 200 day simple moving average of $209.31. Teleflex has a 12 month low of $166.76 and a 12 month high of $256.85. The firm has a market capitalization of $7.78 billion, a P/E ratio of 33.29, a PEG ratio of 1.72 and a beta of 1.16.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.